Ekso Bionics® to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in
exoskeleton technology for medical and industrial use, today
announced that it will release financial and business results for
the fourth quarter and full year 2020 after the close of trading on
Thursday, February 25, 2021. Management will host a conference call
beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial
results and recent business developments.
Investors interested in listening to the
conference call may do so by dialing 877-407-3036 for domestic
callers or 201-378-4919 for international callers. A live webcast
of the event will be available in the “Investors” section of the
company’s website at www.eksobionics.com, or by clicking here.
A replay of the call will be available for two
weeks by dialing 877-660-6853 for domestic callers or 201-612-7415
for international callers and using Conference ID: 13715338. The
webcast will also be available on the Company’s website for one
month following the completion of the call.
Bionics® Ekso Bionics® is a leading
developer of exoskeleton solutions that amplify human potential by
supporting or enhancing strength, endurance and mobility across
medical and industrial applications. Founded in 2005, the Company
continues to build upon its industry-leading expertise to design
some of the most cutting-edge, innovative wearable robots available
on the market. Ekso Bionics is the only exoskeleton company to
offer technologies that range from helping those with paralysis to
stand up and walk, to enhancing human capabilities on job sites
across the globe. The Company is headquartered in the San Francisco
Bay Area and is listed on the Nasdaq Capital Market under the
symbol “EKSO.” For more information, visit: www.eksobionics.com or
follow @EksoBionics on Twitter.
Investor Contact: David Carey212-867-1768